Division of Endocrinology and Diabetes, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010-2970, USA.
J Clin Endocrinol Metab. 2013 Mar;98(3):989-94. doi: 10.1210/jc.2012-2747. Epub 2013 Jan 24.
Nephrocalcinosis is a complication of hypoparathyroidism and other metabolic disorders. Imaging modalities include ultrasonography (US) and computed tomography (CT). Few studies have compared these modalities, and standard clinical practice is not defined.
The objective of the study was to determine the preferred method for assessing nephrocalcinosis.
The design of the study was a retrospective, blinded analysis.
The study was conducted at a clinical research center.
Twenty-two hypoparathyroid subjects and 7 controls participated in the study.
Contemporaneous renal US and CT images were reviewed in triplicate by 4 blinded radiologists. Nephrocalcinosis was classified using a 0-3 scale with 0 meaning no nephrocalcinosis and 3 meaning severe nephrocalcinosis.
Intraobserver, interobserver, and interdevice agreements were measured.
Intraobserver agreement was high, with an overall weighted kappa of 0.83 for CT and 0.89 for US. Interobserver agreement was similar between modalities, with kappas of 0.74 for US and 0.70 for CT. Only moderate agreement was found between US and CT scores, with an intermodality kappa of 0.47 and 60% concordance. Of discordant pairs, 81% had higher US scores and only 19% had higher CT scores. Of nephrocalcinosis seen on US and not CT, 45%, 46%, and 9% were grades 1, 2, and 3, respectively. Overall, US scores were higher than CT with a cumulative odds ratio (95% confidence interval) of 5.97 (2.60, 13.75) (P < .01). In controls, 100% of US ratings were 0, and 95% of CT ratings were 0.
US is superior to CT for assessment of mild to moderate nephrocalcinosis in patients with hypoparathyroidism. This finding, in combination with its low cost, lack of radiation, and portability, defines US as the preferred modality for assessment of nephrocalcinosis.
肾钙质沉着症是甲状旁腺功能减退症和其他代谢紊乱的并发症。成像方式包括超声检查(US)和计算机断层扫描(CT)。很少有研究比较这些方法,也没有明确标准的临床实践。
本研究旨在确定评估肾钙质沉着症的首选方法。
研究设计为回顾性、盲法分析。
研究在临床研究中心进行。
22 例甲状旁腺功能减退症患者和 7 例对照者参与了研究。
由 4 位盲法放射科医生对同时期的肾脏 US 和 CT 图像进行了 3 次重复评估。肾钙质沉着症采用 0-3 级评分,0 表示无肾钙质沉着症,3 表示严重肾钙质沉着症。
测量观察者内、观察者间和设备间的一致性。
观察者内一致性较高,CT 的总体加权 κ 值为 0.83,US 为 0.89。两种模态的观察者间一致性相似,US 的 κ 值为 0.74,CT 为 0.70。US 和 CT 评分之间仅存在中度一致性,间模态 κ 值为 0.47,一致性为 60%。在不一致的对中,81%的 US 评分较高,只有 19%的 CT 评分较高。在 US 可见而 CT 不可见的肾钙质沉着症中,分别有 45%、46%和 9%为 1、2 和 3 级。总体而言,US 评分高于 CT,累积优势比(95%置信区间)为 5.97(2.60,13.75)(P<.01)。在对照者中,100%的 US 评分为 0,95%的 CT 评分为 0。
在甲状旁腺功能减退症患者中,US 优于 CT 评估轻度至中度肾钙质沉着症。这一发现,加上其成本低、无辐射和便携性,使 US 成为评估肾钙质沉着症的首选方法。